Biozorb
Payments companies reported to CMS as associated with Biozorb. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Biozorb, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Biozorb
These are the largest totals companies reported as associated with Biozorb. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Marguerite Brackley | Marlborough, MA | Internal Medicine | $190,450.00 |
| Amy Pollack | New York, NY | Obstetrics & Gynecology | $184,437.50 |
| Valerie Gorman | Waxahachie, TX | Surgery | $38,673.01 |
| Linda Han | Germantown, TN | Surgery | $27,217.62 |
| Lorraine Tafra | Annapolis, MD | Surgery | $23,100.00 |
| Barry Rosen | Barrington, IL | Surgery | $17,025.89 |
| Shawna Willey | Fairfax, VA | Surgical Oncology | $16,130.74 |
| Jean-Claude Schwartz | Statesboro, GA | Surgery | $12,974.36 |
| Ross Segan | North Haven, CT | Surgery | $12,025.00 |
| Karen Barbosa | Rehoboth Beach, DE | Surgery | $11,494.73 |
Prescribed Biozorb?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.